Call for student team applications: Innovate4Health 2022

Organized by the ReAct—Action on Antibiotic Resistance, the International Federation of Medical Students’ Associations (IFMSA), and the IDEA (Innovation + Design Enabling Access) Initiative at the Johns Hopkins Bloomberg School of Public Health, Innovate4Health offers student teams the opportunity to join the front lines of the fight against antimicrobial resistance and COVID-19. This year, student teams are encouraged to innovate around one of three pillars: 1) Ensuring effective prevention and treatment of emerging infectious diseases in the healthcare delivery system; 2) Reducing the use and the need to use antimicrobials in food systems; and 3) Making community health systems more resilient to emerging infectious diseases.

Taking a systems approach, Innovate4Health emphasizes social innovations that consider the needs of resource-limited settings. We are looking for student teams (2-5 students per team) with ideas for innovative solutions and an interest in continuing to develop and refine their ideas in a design sprint curriculum. Through the design sprint, teams will work through ideation, implementation, and advocacy strategies to support the adoption of these approaches. We have continued to evolve the design sprint’s activities to strengthen its value for participating teams. This year’s cohort will have the opportunity to develop stage-specific strategies to write a blog advancing the social mission behind the team’s innovation; prepare a poster presentation of their project; and put together a social media advocacy piece. A group of experts will coach the team on its final presentation, which will be shared as a recording. The selected teams will work with a team of experts and coaches to co-construct their solutions through both recorded and live learning sessions. We invite applications from teams that would be excited to collaborate with other highly talented student teams. The design sprint will extend from October 2022 through January 2023.

Students do not need any previous experience involving antimicrobial resistance (AMR) or other emerging infectious diseases. In the competitive application process, we are looking for student teams providing a vision for what they might want to innovate, including the specific problem and context, as well as sharing how they might be positioned to help implement such a project. At the application stage, however, we do not expect fully developed projects. The design sprint process is intended to help teams develop further their ideas from the application stage. We have outlined additional information for Innovate4Health on our website, There, you will also find more background information on Innovate4Health, as well as the design sprint timeline, Terms and Conditions, and submission guidelines. Last year, over 70 student teams answered our call for Innovate4AMR applications, and only 15 finalist teams were selected.

The deadline for team applications is Monday, September 19, 2022. We will be releasing additional resources to support teams in developing applications, and interested students can sign up for updates here.

Issues Related to the Treatment of H. pylori Infection in People Living with HIV and Receiving Antiretrovirals

Treatment of Helicobacter pylori infection in people living with HIV is associated with several challenges, including those related to drug metabolism which plays a major role in treatment efficacy. In this review, we will discuss the enzymes involved in the metabolism of anti-Helicobacter pylori and anti-HIV drugs to provide a basis for understanding the potential for interactions between these drug classes. We will also provide a clinical perspective on other issues related to the treatment of Helicobacter pylori and HIV infections such as comorbidities, adherence, and peer communication. Finally, based on our understanding of the interplay between the above issues, we propose a new concept “Antimicrobial susceptibility testing-drug interaction-supports-referent physician” (AISR), to provide a framework for improving rates of H. pylori eradication in people living with HIV…more